Lars Boesgaard Form 3 Roka BioScience / Lars Boesgaard ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Boesgaard Lars

(Last) (First) (Middle)

20 INDEPENDENCE BLVD

(Street)

WARREN NJ 07059

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/12/2015

3. Issuer Name and Ticker or Trading Symbol
Roka BioScience, Inc. [ ROKA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Vice President, CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	53,792	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	04/02/2011(1)	04/01/2020	Common Stock	6,757	1.766	D
Stock Option (right to buy)	06/30/2011(2)	06/29/2020	Common Stock	4,565	1.766	D
Stock Option (right to buy)	02/01/2013(3)	01/31/2022	Common Stock	20,380	3.643	D
Stock Option (right to buy)	01/01/2014(4)	12/31/2022	Common Stock	9,963	0.993	D
Stock Option (right to buy)	01/02/2016(5)	01/01/2025	Common Stock	23,000	4.36	D

Explanation of Responses:

1. Such stock options vested 25% on April 2, 2011 and in 1/36th increments on a monthly basis beginning one month after that. As of the date of this Form 3, all such stock options are vested. The stock options have a term of ten years.

2. Such stock options vested 25% on June 30, 2011 and in 1/36th increments on a monthly basis beginning one month after that. As of the date of this Form 3, all such stock options are vested. The stock options have a term of ten years.

3. Such stock options vested 25% on February 1, 2013 and vest in 1/36th increments on a monthly basis beginning one month after that. The stock options have a term of ten years.

4. Such stock options vested 25% on January 1, 2014 and vest in 1/36th increments on a monthly basis beginning one month after that. The stock options have a term of ten years.

5. Such stock options vest 25% on January 2, 2016 and in 1/36th increments on a monthly basis beginning one month after that. The stock options have a term of ten years.

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Corey Swanson, attorney in fact	11/18/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.